Pressure Wire Guided Cardiac Resynchronisation Therapy

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 282 participants.

Also called NCT01464502

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 2/3
Enrolled
  • 282 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01464502
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Italy, United Kingdom (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01464502. Randomized; no masking; primary purpose treatment. Start 2012-09 (registry gives no type); primary completion 2018-04 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Pressure Wire Guided Cardiac Resynchronisation Therapy
Condition
Heart Failure
Intervention (Procedure)
Standard CRT Implant
Intervention (Procedure)
Pressure-wire guided CRT implant
Lead sponsor
Guy's and St Thomas' NHS Foundation Trust (class: other)
Collaborator
Abbott Medical Devices (class: industry)

Record details

Record id
cardio:ct-nct01464502
Content hash
b7b0173f0855ec385adad994f190a0535074d603fba88dade9c035a8c6ab181c